Evidence map›Paper›PMID 26958855›Full record

ArticlePloS one2016

Epidemiology, Seasonality and Treatment of Hospitalized Adults and Adolescents with Influenza in Jingzhou, China, 2010-2012.

Jiandong Zheng, Xixiang Huo, Yang Huai, Lin Xiao, Hui Jiang, John Klena, Carolyn M Greene, Xuesen Xing, Jigui Huang, Shali Liu and 15 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Notifiable Respiratory Infectious Diseases in China: A Spatial-Temporal Epidemiology Analysis.International journal of environmental research and public health · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 2 countries.

Jiandong ZhengDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Xixiang HuoHubei Provincial Centre for Disease Control and Prevention, Wuhan, China.
Yang HuaiChina-US Collaborative Program on Emerging and Re-emerging Infection Disease, Center for Global Health, Centers for Disease Control and Prevention, Beijing, China.
Lin XiaoJingzhou Center for Disease Control and Prevention, Jingzhou, China.
Hui JiangDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
John KlenaChina-US Collaborative Program on Emerging and Re-emerging Infection Disease, Center for Global Health, Centers for Disease Control and Prevention, Beijing, China.
Carolyn M GreeneChina-US Collaborative Program on Emerging and Re-emerging Infection Disease, Center for Global Health, Centers for Disease Control and Prevention, Beijing, China.
Xuesen XingHubei Provincial Centre for Disease Control and Prevention, Wuhan, China.
Jigui HuangJingzhou Center for Disease Control and Prevention, Jingzhou, China.
Shali LiuJingzhou Central Hospital, Jingzhou, China.
Youxing PengJingzhou First People's Hospital, Jingzhou, China.
Hui YangJingzhou Second People's Hospital, Jingzhou, China.
Jun LuoJingzhou Maternal and Children's Hospital, Jingzhou, China.
Zhibin PengDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Linlin LiuHubei Provincial Centre for Disease Control and Prevention, Wuhan, China.
Maoyi ChenJingzhou Center for Disease Control and Prevention, Jingzhou, China.
Hui ChenHubei Provincial Centre for Disease Control and Prevention, Wuhan, China.
Yuzhi ZhangChina-US Collaborative Program on Emerging and Re-emerging Infection Disease, Center for Global Health, Centers for Disease Control and Prevention, Beijing, China.
Danqin HuangHubei Provincial Centre for Disease Control and Prevention, Wuhan, China.
Xuhua GuanHubei Provincial Centre for Disease Control and Prevention, Wuhan, China.
Luzhao FengDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Faxian ZhanHubei Provincial Centre for Disease Control and Prevention, Wuhan, China.
Dale J HuChina-US Collaborative Program on Emerging and Re-emerging Infection Disease, Center for Global Health, Centers for Disease Control and Prevention, Beijing, China.
Jay K VarmaChina-US Collaborative Program on Emerging and Re-emerging Infection Disease, Center for Global Health, Centers for Disease Control and Prevention, Beijing, China.
Hongjie YuDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Hubei Provincial Center for Disease Control and Prevention · CNChinese Center For Disease Control and Prevention · CNJingzhou Central Hospital · CNCenters for Disease Control and Prevention · USFirst People's Hospital of Jingzhou · CNJingzhou Maternal and Child Health Hospital · CNNational Institute of Allergy and Infectious Diseases · USXian Yang Central Hospital · CN

Funding

CGH CDC HHS U2G GH000018PHS HHS 5U2GGH000018
6 · The paper itself

Abstract

backgroundAfter the 2009 influenza A (H1N1) pandemic, we conducted hospital-based severe acute respiratory infection (SARI) surveillance in one central Chinese city to assess disease burden attributable to influenza among adults and adolescents.

methodsWe defined an adult SARI case as a hospitalized patient aged ≥ 15 years with temperature ≥38.0°C and at least one of the following: cough, sore throat, tachypnea, difficulty breathing, abnormal breath sounds on auscultation, sputum production, hemoptysis, chest pain, or chest radiograph consistent with pneumonia. For each enrolled SARI case-patient, we completed a standardized case report form, and collected a nasopharyngeal swab within 24 hours of admission. Specimens were tested for influenza viruses by real-time reverse transcription polymerase chain reaction (rRT-PCR). We analyzed data from adult SARI cases in four hospitals in Jingzhou, China from April 2010 to April 2012.

resultsOf 1,790 adult SARI patients enrolled, 40% were aged ≥ 65 years old. The median duration of hospitalization was 9 days. Nearly all were prescribed antibiotics during their hospitalization, less than 1% were prescribed oseltamivir, and 28% were prescribed corticosteroids. Only 0.1% reported receiving influenza vaccination in the past year. Of 1,704 samples tested, 16% were positive for influenza. Influenza activity in all age groups showed winter-spring and summer peaks. Influenza-positive patients had a longer duration from illness onset to hospitalization and a shorter duration from hospital admission to discharge or death compared to influenza negative SARI patients.

conclusionsThere is substantial burden of influenza-associated SARI hospitalizations in Jingzhou, China, especially among older adults. More effective promotion of annual seasonal influenza vaccination and timely oseltamivir treatment among high risk groups may improve influenza prevention and control in China.

Indexed as

HospitalizationSeasonsAcute DiseaseAdolescentAdultAgedChinaFemaleHumansInfluenza, HumanMaleMiddle AgedYoung Adult

Identifiers

PMID26958855
PMCPMC4784897
OpenAlexW2296682696

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.